
Cell, Год журнала: 2025, Номер unknown
Опубликована: Март 1, 2025
Язык: Английский
Cell, Год журнала: 2025, Номер unknown
Опубликована: Март 1, 2025
Язык: Английский
Опубликована: Окт. 4, 2024
Язык: Английский
Процитировано
8Cell Reports Methods, Год журнала: 2024, Номер unknown, С. 100910 - 100910
Опубликована: Дек. 1, 2024
Язык: Английский
Процитировано
7National Science Review, Год журнала: 2024, Номер 11(9)
Опубликована: Июль 10, 2024
ABSTRACT Therapeutics targeting tumor endothelial cells (TECs) have been explored for decades, with only suboptimal efficacy achieved, partly due to an insufficient understanding of the TEC heterogeneity across cancer patients. We integrated single-cell RNA-seq data 575 patients from 19 solid types, comprehensively charting phenotypic diversities. Our analyses uncovered underappreciated compositional and functional in TECs a pan-cancer perspective. Two subsets, CXCR4+ tip SELE+ veins, represented prominent angiogenic proinflammatory phenotypes TECs, respectively. They exhibited distinct spatial organization patterns, compared adjacent non-tumor tissues, tissue showed increased prevalence cells, yet veins depleted. Such characteristics underlie their differential associations response anti-angiogenic therapies immunotherapies. integrative resources findings open new avenues understand clinically intervene vasculature.
Язык: Английский
Процитировано
6Bioorganic Chemistry, Год журнала: 2024, Номер 145, С. 107157 - 107157
Опубликована: Фев. 7, 2024
Язык: Английский
Процитировано
4Food Bioscience, Год журнала: 2024, Номер unknown, С. 105243 - 105243
Опубликована: Окт. 1, 2024
Язык: Английский
Процитировано
4Advanced Science, Год журнала: 2024, Номер 12(2)
Опубликована: Ноя. 13, 2024
Abstract With the increasing demand for precision medicine in cancer patients, radiogenomics emerges as a promising frontier. Radiogenomics is originally defined methodology associating gene expression information from high‐throughput technologies with imaging phenotypes. However, advancements medical imaging, omics technologies, and artificial intelligence, both concept application of have significantly broadened. In this review, history enumerated, related five basic workflows their applications across tumors, role AI radiogenomics, opportunities challenges tumor heterogeneity, immune microenvironment. The positron emission tomography multi‐omics studies also discussed. Finally, faced by clinical transformation, along future trends field
Язык: Английский
Процитировано
4European journal of medical research, Год журнала: 2025, Номер 30(1)
Опубликована: Март 13, 2025
Microvascular invasion (MVI) represents a pivotal independent prognostic factor for the recurrence of hepatocellular carcinoma (HCC) after surgery. It contributes to early intervention potentially recurrent HCC enhance patient outcomes and increase survival rates. Traditionally, diagnosis MVI has relied on postoperative pathological analysis, accurate preoperative detection methodologies are lacking. Recent research suggests that multi-omics strategies play role in definitively diagnosing before surgery offering personalized selection clinical decision-making management. This review meticulously examines approach prediction patients, aiming innovate diagnostic paradigms anticipate postsurgical recurrence, thereby facilitating earlier more therapeutic strategies.
Язык: Английский
Процитировано
0Journal of Translational Medicine, Год журнала: 2025, Номер 23(1)
Опубликована: Март 27, 2025
The identification of the complex spatial architecture immune cell infiltration and its interaction mechanisms within tumor ecosystems provides crucial insights into therapeutic responses to neoadjuvant therapy in muscle-invasive bladder cancer (MIBC). This study aims characterize features distinct cell-type niches microenvironment (TME) patients with varying therapy. We performed transcriptomic profiling on six MIBC specimens obtained from a registered clinical trial (ChiCTR2000032359), generating whole-transcriptome atlases map TME architecture. High-throughput analytical frameworks were employed deconstruct TME, key findings validated through immunohistochemistry mouse model experiments. Our analysis revealed that tissues complete responders exhibited greater T B cells, formation tertiary lymphoid structure (TLS). Trajectory identified CCL19/CCL21 as signaling molecules driving TLS MIBC. Mouse experiments demonstrated recombinant protein injections promoted intratumoral enhance efficacy immunotherapy. Furthermore, we observed significant intrinsic heterogeneity individual tumors, which may contribute lack underscores critical role response drivers tumors potential immune-sensitizing agents. Additionally, should be considered factor influencing efficacy.
Язык: Английский
Процитировано
0Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, Год журнала: 2025, Номер unknown, С. 189336 - 189336
Опубликована: Апрель 1, 2025
Язык: Английский
Процитировано
0European Journal of Medicinal Chemistry, Год журнала: 2023, Номер 263, С. 115937 - 115937
Опубликована: Ноя. 10, 2023
Язык: Английский
Процитировано
10